GenixPharmaceucticals Corporation (GENX : TSX-V)
Common Stock
$0.02
CAD
+0.00 (%)
Last updated: 2026-07-03
GENX
GenixPharmaceucticals Corporation
WealthAwesomePerformance
1 Day
+0.00%
1 Week
+0.00%
1 Month
+0.00%
YTD
-20.00%
Key Statistics
Market Cap
$918,361
52W High
$0.04
52W Low
$0.02
P/E Ratio
-
50 Day MA
$0.02
200 Day MA
$0.02
Beta
0.40
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/3/2026 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 0 |
| 7/2/2026 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 0 |
| 6/29/2026 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 0 |
| 6/25/2026 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 0 |
| 6/17/2026 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 0 |
| 6/16/2026 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 0 |
| 6/12/2026 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 0 |
| 5/27/2026 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 0 |
| 5/26/2026 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 0 |
| 5/25/2026 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 0 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on GENX's historical volatility
30-Day Vol
230.0%
Annualized
90-Day Vol
267.5%
Annualized
Trend (90d)
+0.0%
Annualized drift
90d Mean
C$0.02
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.02 | C$0.01 – C$0.04 |
| 60 trading days | C$0.02 | C$0.01 – C$0.06 |
| 90 trading days | C$0.02 | C$0.01 – C$0.08 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About GenixPharmaceucticals Corporation
Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with a focus on nutraceuticals and pharmaceuticals in Canada. The company offers generic ophthalmic prescription products, ophthalmic nutraceutical formulations, and prescription generic drugs; ophthalmic OTC products; and eye ointments and drops. It also provides Flu-X, an anti-viral, anti-flu, and common colds coronavirus oral and spray herbal product; Rechlor, a dietary supplement to support kidney health; Sucanon, an herbal health supplement to manage blood sugar levels and enhance insulin sensitivity in non-insulin dependent adults; and Synthroid, a levothyroxine sodium drug for the treatment of hypothyroidism. The company was formerly known as Alta Natural Herbs & Supplements Ltd. and changed its name to Genix Pharmaceuticals Corporation in June 2019. Genix Pharmaceuticals Corporation was incorporated in 1993 and is based in Vancouver, Canada.
Financials
- Revenue (TTM)
- $68
- EBITDA
- $-124,839
- Profit Margin
- 0.00%
- ROE (TTM)
- -661.13%
- EPS (Diluted)
- -0.01
- Book Value
- -0.03
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About GENX
Articles Featuring GENX.V
Latest articles and analysis covering GENX.V
Why GenixPharmaceucticals Corporation stock is plummeting today
GenixPharmaceucticals Corporation (GENX.V) experienced a steep decline in its stock price today, closing down 25%. With no recent positive developments, investors are left questioning the company's viability.
What to Expect from Genix Pharmaceuticals' Recent Earnings Report
Genix Pharmaceuticals' upcoming earnings report raises questions as no EPS estimates are available. Recent leadership changes and fundraising efforts may influence the results.
